- About Us
- Services & Solutions
- Technologies
- Discovery
- Reagent Materials Generation
- Monoclonal Antibody Discovery
- Bispecific & Multispecific Antibody Generation
- Lead Optimization
- In Vitro Lead Characterization
- In Vivo Lead Characterization
- Other Molecular Modalities
- IND Filing Support
- Protein Sciences
- Antibody Production
- Protein Production
- Protein Characterization
- Protein Sciences
- Mammalian
- Microbial
- mRNA
- Viral Vaccines
- WuXi XDC – Bioconjugation
- Testing
- Sustainability
- Careers
- Investors
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- SustainabilityAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Services & Solutions
Information Downloads
WuXiBody & SDARBody
Novel Technologies Providing Flexible Valency and Outstanding Developability
|
Bispecific antibodies (bsAbs) and multispecific antibodies (msAbs) are a growing class of next-generation biotherapeutics. To support our clients and to overcome the challenges associated with these complex modalities, WuXi Biologics has established bsAb and msAb engineering and development platforms. |
Discuss This Service Overview
To discuss the information in this service overview, please complete the form on the following page to connect with our experts.